Guidelines on high blood pressure in pregnancy give new classifications of disease.
Rollins
G
G
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use; D000075202:Contraindications; D005260:Female; D006801:Humans; D006973:Hypertension / Q000145:classification / Q000150:complications / Q000188:drug therapy; D007741:Labetalol / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011225:Pre-Eclampsia / Q000150:complications / Q000188:drug therapy; D011247:Pregnancy; D014481:United States
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001262:Atenolol; D008750:Methyldopa; D007741:Labetalol